Imara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Imara and buy or sell other stocks, options, and ETFs commission-free!About IMRA
Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates.
CEOSamuel S. Kintz, MBA
CEOSamuel S. Kintz, MBA
Employees46
Employees46
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2019
Founded2019
Employees46
Employees46
IMRA Key Statistics
Market cap260.97M
Market cap260.97M
Price-Earnings ratio-7.70
Price-Earnings ratio-7.70
Dividend yield—
Dividend yield—
Average volume438.14K
Average volume438.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$26.00
52 Week high$26.00
52 Week low$9.80
52 Week low$9.80